UNLIMITED FREE ACCESS TO THE WORLD'S BEST IDEAS

close
Already an Engineering360 user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your Engineering360 Experience

close
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

CLSI C57

Mass Spectrometry for Androgen and Estrogen Measurements in Serum

active, Most Current
Buy Now
Organization: CLSI
Publication Date: 1 February 2015
Status: active
Page Count: 68
scope:

This guideline describes principles, requirements, and recommendations of current mass spectrometry (MS) measurement procedures for routine analysis of androgens and estrogens in serum. The main focus of this document is on the analytical validation and clinical application of androgen and estrogen measurement procedures using MS. It includes guidance, references, and QA parameters that will assist with the implementation and operation of MS systems. Information on maintaining appropriate instrument settings and performance parameters, approaches to ensure accurate and precise measurements, measurement procedure validation requirements, QA procedures, and interpretation and reporting of results are included. Recommendations are included for sample preparation, and pre- and postexamination (pre- and postanalytical) considerations.

The intended users of this guideline are laboratorians who perform or plan to perform androgen and/or estrogen tests by MS, MS assay developers, and physicians and researchers involved in androgen and/or estrogen testing.

A general, comprehensive review of MS technologies in the clinical laboratory is provided in CLSI document C50.3 This guideline is limited to the measurement of total androgens and/or estrogens in serum, referring to the free, bioavailable, albumin-bound androgens and estrogens, and free, bioavailable, sex hormone-binding globulin (SHBG)-bound androgens and estrogens. The focus of this guideline is limited to the measurement of androgens and estrogens commonly used in clinical and research settings that include, but are not limited to: dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEAs), androstenedione, testosterone (T), dihydrotestosterone (DHT), estrone (E1), estrone sulfate (E1s), estradiol (E2), and estriol (E3). This guideline provides information on MS that relates to testing of the above-mentioned steroid hormones. In addition, the purpose of this document is to provide guidance on the appropriate use of MS for androgen and estrogen measurements and cannot cover all the possibilities in this rapidly developing field. The recommendations provided should be interpreted in light of the continuing progression in this discipline.

Document History

February 1, 2015
Mass Spectrometry for Androgen and Estrogen Measurements in Serum
This guideline describes principles, requirements, and recommendations of current mass spectrometry (MS) measurement procedures for routine analysis of androgens and estrogens in serum. The main...
CLSI C57
February 1, 2015
Mass Spectrometry for Androgen and Estrogen Measurements in Serum
This guideline describes principles, requirements, and recommendations of current mass spectrometry (MS) measurement procedures for routine analysis of androgens and estrogens in serum. The main...

References

Advertisement